{
    "nctId": "NCT00900302",
    "briefTitle": "OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer",
    "officialTitle": "Study of The Examination of Sentinel Lymph Nodes for OX-40 Expression in Patients With Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 98,
    "primaryOutcomeMeasure": "OX-40 expression",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically or cytologically confirmed cancer, including, but not limited to, the following:\n\n  * Melanoma\n  * Breast cancer\n  * Invasive squamous cell cancer\n  * Other cancers for which patients underwent or will undergo the following:\n\n    * Adequate archived paraffin-embedded tissue for making slides for immunostaining\n    * Adequate freshly removed sentinel lymph node (and primary tumor, if available) tissue for laboratory assays\n* Clinical data and date of last follow-up on tumor stage and status must be available\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Not specified\n\nPRIOR CONCURRENT THERAPY:\n\n* Not specified",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}